glutamic acid has been researched along with Diabetic Neuropathies in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lin, B; Lu, Y; Zhong, J | 1 |
| Bhattarai, JP; Cho, DH; Han, SK; Lee, JC; Nguyen, HT; Park, SJ | 1 |
| Adrian, TE; Hussain, N | 1 |
| Cheng, JK; Hou, SY; Huang, YH; Lin, CR; Wu, CH | 1 |
| Cai, YQ; Chen, H; Chen, SR; Li, JQ; Pan, HL | 1 |
| Ghazi-Khansari, M; Jaberi, E; Mohammadi-Farani, A; Sahebgharani, M; Sepehrizadeh, Z | 1 |
| Carozzi, VA; Ceresa, C | 1 |
| Ishii, K; Mori, A; Nakahara, T; Sakamoto, K; Tsuda, Y; Ueda, K | 1 |
| Andrews, NA; Blake, R; Maneuf, YP; McKnight, AT | 1 |
| Boulis, NM; Federici, T; Garrity-Moses, ME; Krudy, C; Teng, Q; Yang, J | 1 |
| Calcutt, NA; Ceseña, R; Glennon, JC; Malmberg, AB; O'Connor, WT | 1 |
| Chen, SR; Pan, HL; Wang, XL; Zhang, HM | 1 |
| Anjaneyulu, M; Berent-Spillson, A; Russell, JW | 1 |
| Cai, H; Colagiuri, S; Wang, X; Wilcken, DE | 1 |
| Srinivasan, S; Stevens, M; Wiley, JW | 1 |
3 review(s) available for glutamic acid and Diabetic Neuropathies
| Article | Year |
|---|---|
Diabetic Neuropathy: Update on Pathophysiological Mechanism and the Possible Involvement of Glutamate Pathways.
Topics: Animals; Diabetic Neuropathies; Glutamic Acid; Glycation End Products, Advanced; Hexosamines; Humans; Inflammation; Metabolic Networks and Pathways; Oxidative Stress; Polymers; Protein Kinase C | 2017 |
The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II.
Topics: Animals; Antineoplastic Agents; Diabetic Neuropathies; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Neuroprotective Agents; Peripheral Nervous System; Peripheral Nervous System Diseases | 2012 |
Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy.
Topics: Animals; Diabetic Neuropathies; Disease Models, Animal; Gene Expression; Glutamic Acid; Humans; Neurons; Oxidative Stress; Receptors, Metabotropic Glutamate; Signal Transduction | 2008 |
12 other study(ies) available for glutamic acid and Diabetic Neuropathies
| Article | Year |
|---|---|
The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glutamic Acid; Hyperalgesia; Inflammation; Interleukin-1beta; Male; Microglia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha; Yohimbine | 2017 |
Enhanced GABA action on the substantia gelatinosa neurons of the medullary dorsal horn in the offspring of streptozotocin-injected mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes, Gestational; Diabetic Neuropathies; Facial Nerve Diseases; Facial Pain; Female; Fetal Development; gamma-Aminobutyric Acid; Glutamic Acid; Glycine; Growth Disorders; Male; Mice, Inbred ICR; Pregnancy; Pregnancy in Diabetics; Streptozocin; Substantia Gelatinosa; Synaptic Transmission; Trigeminal Caudal Nucleus; Up-Regulation | 2015 |
Pulsed radiofrequency attenuates diabetic neuropathic pain and suppresses formalin-evoked spinal glutamate release in rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Formaldehyde; Glutamic Acid; Male; Neuralgia; Pulsed Radiofrequency Treatment; Rats; Rats, Sprague-Dawley; Secretory Pathway | 2016 |
Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain.
Topics: Animals; Chromones; Diabetic Neuropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Glutamic Acid; Male; Pain Measurement; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Spinal Cord | 2010 |
Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Topics: Analgesia; Analgesics; Animals; Benzoxazines; Capsaicin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Down-Regulation; gamma-Aminobutyric Acid; Glutamic Acid; Hyperalgesia; Male; Morpholines; Naphthalenes; Neural Inhibition; Neurons; Nociceptors; Periaqueductal Gray; Rats; Receptor, Cannabinoid, CB1; RNA, Messenger; TRPV Cation Channels; Up-Regulation | 2010 |
Effect of nafamostat on N-methyl-D-aspartate-induced retinal neuronal and capillary degeneration in rats.
Topics: Animals; Basement Membrane; Benzamidines; Capillaries; Diabetic Neuropathies; Excitatory Amino Acid Agonists; Glaucoma; Glutamic Acid; Guanidines; Intravitreal Injections; Male; N-Methylaspartate; Nerve Degeneration; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Neurons; Retinal Vessels; Serine Proteinase Inhibitors; Severity of Illness Index; Vascular Diseases | 2012 |
Reduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat.
Topics: Acetates; Amines; Animals; Blood Glucose; Cyclohexanecarboxylic Acids; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Male; Pain; Pain Measurement; Physical Stimulation; Potassium; Rats; Trigeminal Nuclei | 2004 |
X-Linked inhibitor of apoptosis protein gene-based neuroprotection for the peripheral nervous system.
Topics: Amyotrophic Lateral Sclerosis; Apoptosis; Caspase 3; Caspases; Cell Count; Cell Line; Cell Survival; Diabetic Neuropathies; Feasibility Studies; Ganglia, Spinal; Gene Expression; Gene Transfer Techniques; Glutamic Acid; Green Fluorescent Proteins; Humans; Motor Neurons; Neuroprotective Agents; Peripheral Nervous System; Recombinant Fusion Proteins; X-Linked Inhibitor of Apoptosis Protein | 2006 |
Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats.
Topics: Afferent Pathways; Amino Acids; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Down-Regulation; Extracellular Fluid; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hyperalgesia; Microdialysis; Neurons, Afferent; Nociceptors; Pain Measurement; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Spinal Cord; Spinal Nerve Roots; Up-Regulation | 2006 |
Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy.
Topics: Animals; Baclofen; Bicuculline; Diabetic Neuropathies; Disease Models, Animal; Excitatory Postsynaptic Potentials; GABA Agonists; GABA Antagonists; Glutamic Acid; Glycine; Interneurons; Male; Neural Inhibition; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, GABA-B; Synapses; Synaptic Transmission | 2007 |
A common Glu298-->Asp (894G-->T) mutation at exon 7 of the endothelial nitric oxide synthase gene and vascular complications in type 2 diabetes.
Topics: Albuminuria; Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cerebrovascular Disorders; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Exons; Genotype; Glutamic Acid; Humans; Middle Aged; Myocardial Infarction; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Peripheral Vascular Diseases; Point Mutation; Risk Factors | 1998 |
Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction.
Topics: Animals; Apoptosis; Blood Glucose; Cytochrome c Group; Cytoplasm; Diabetic Neuropathies; Drug Implants; Ganglia, Spinal; Glutamic Acid; Insulin; Male; Membrane Potentials; Mitochondria; Neurons; Peripheral Nervous System Diseases; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley | 2000 |